Washington Trust Advisors, Inc.
Position in BTAI — BioXcel Therapeutics, Inc.
CIK 1900099
WELLESLEY, MA
Position in BTAI
as of Mar 31, 2026
· filed Apr 6, 2026
Position Value
$214
-$42 QoQ
Shares Held
160
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 40 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Washington Trust Advisors, Inc. holds $218,919 across 5 Drug Manufacturers - Specialty & Generic names. BTAI ranks #5 (0.1% of the industry book) .
All Filings in BTAI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $214 | 160 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $256 | 160 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $409 | 160 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $289 | 160 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $324 | 160 | Shares | Sole | 2025-04-25 | |
| No filing history on record for this holder in this stock. | ||||||